Sermorelin clears from the blood in about 11 to 12 minutes, but a bedtime dose is still measurable the next morning. The reason is downstream: IGF-1, the molecule sermorelin raises, has a half-life of 12 to 15 hours, so the effect long outlasts the drug.
Sermorelin has a half-life of about 11 to 12 minutes. That figure comes from the FDA-approved prescribing information for Geref, the discontinued brand of sermorelin acetate [1]. The peptide clears from circulation fast. Its clinical effect is measured not by how long the drug lasts but by the IGF-1 response it sets in motion.
- Sermorelin's plasma half-life is about 11 to 12 minutes [1]
- The short half-life is intentional: a brief GHRH signal produces a natural-shaped GH pulse [3]
- Native GHRH(1-29) is even shorter, around 4 minutes, which is why longer analogs were engineered [2]
- The downstream marker IGF-1 has a half-life of 12 to 15 hours, so effects outlast the drug [4]
- Longer-acting analogs like CJC-1295 stretch the half-life to 5.8 to 8.1 days for less frequent dosing [5]
What Half-Life Means Here
Half-life is the time for plasma concentration to fall by half. For sermorelin, that is roughly 11 to 12 minutes, so within about an hour the peptide is largely gone from the blood [1]. For a drug that replaced a hormone directly, that would be a problem. For a GHRH analog, it is the point.
Sermorelin does not deliver growth hormone. It is a 29-amino-acid analog of the active fragment of GHRH that binds pituitary receptors and prompts the gland to release its own GH [6]. A short pulse of stimulation is exactly what the pituitary is built to answer.
Why Short Is By Design
Natural GH release is pulsatile, not continuous. The hypothalamus sends GHRH in bursts, the pituitary answers with a GH pulse, and somatostatin feedback closes the loop [3]. A stimulus that cleared slowly would flatten that rhythm into a plateau, which is closer to how exogenous HGH behaves and part of why it carries different risks.
A short half-life reproduces the natural shape. Sermorelin triggers a discrete GH pulse and then clears, leaving the somatostatin feedback axis intact to regulate the next one [3]. The pituitary is not overridden, and it is not suppressed.
Endogenous GH release is largest during early slow-wave sleep. A short-acting GHRH analog given at bedtime lands its pulse alongside the body's own largest pulse, which is why the standard protocol is a subcutaneous dose at night.
Native GHRH Is Even Shorter
Sermorelin's brevity is inherited from the hormone it mimics. Native GHRH(1-29) has a half-life of only about 4 minutes because plasma enzymes cleave it quickly [2]. The whole family of longer analogs exists to slow that breakdown.
Substituting a D-alanine at position 2 blocks the main cleavage site. In normal men, that single change increased the half-life and decreased the metabolic clearance of GHRH(1-29) [2]. That is the same modification, taken further, that produces the long-acting analogs.
The Effect Outlasts the Drug
A 12-minute half-life does not mean a 12-minute effect. The peptide is only the trigger. What it produces is a GH pulse, and what that GH produces is IGF-1, the downstream molecule responsible for most clinical effects.
IGF-1 has a half-life of about 12 to 15 hours because it circulates bound to binding proteins that protect it from clearance [4]. A bedtime sermorelin injection is measurable as elevated IGF-1 the next morning. That is why IGF-1, not the sermorelin level, is the lab marker used to judge response, typically drawn at baseline and again around 90 days.
How Longer-Acting Analogs Compare
Not every GHRH analog is short by design. CJC-1295 was engineered for the opposite goal. With its drug-affinity-complex modification, it binds albumin and stretches the half-life to about 5.8 to 8.1 days, which allows once- or twice-weekly dosing instead of nightly [5].
The trade-off is the point of tension. A multi-day half-life means continuous rather than pulsatile stimulation, which moves away from the natural rhythm that short-acting sermorelin preserves. Neither the short nor the long analog is FDA-approved for anti-aging use. Both are compounded.
| Peptide | Approximate half-life | Dosing rhythm |
|---|---|---|
| Native GHRH(1-29) | ~4 minutes [2] | Not used therapeutically |
| Sermorelin | ~11 to 12 minutes [1] | Nightly, mimics a natural pulse |
| CJC-1295 (with DAC) | ~5.8 to 8.1 days [5] | Once or twice weekly |
| IGF-1 (downstream marker) | ~12 to 15 hours [4] | Measured at baseline and ~90 days |
Sermorelin clears in minutes, so the drug level tells you nothing. IGF-1 does. SystemLabs includes baseline IGF-1 testing before prescribing sermorelin, which gives you a real number to retest against around 90 days.
Bottom Line
Frequently Asked Questions
What is the half-life of sermorelin?
About 11 to 12 minutes, based on the FDA-approved prescribing information for Geref sermorelin acetate [1]. The peptide clears from the blood within roughly an hour. Its effect is judged by the downstream IGF-1 response, not by how long the drug itself lasts.
Why does sermorelin have such a short half-life?
Because a short stimulus is what produces a natural GH pulse. Sermorelin is a GHRH analog that prompts the pituitary to release its own growth hormone, and a brief signal preserves the pulsatile rhythm and the somatostatin feedback loop [3]. Native GHRH(1-29) is even shorter at about 4 minutes [2].
How long does sermorelin stay in your system?
The peptide is largely cleared within about an hour, given the 11 to 12 minute half-life [1]. The effect lasts far longer because IGF-1, the molecule it raises, has a half-life of 12 to 15 hours [4]. A bedtime injection remains measurable as elevated IGF-1 the next morning.
Does a short half-life mean sermorelin is less effective?
No. The half-life describes how fast the trigger clears, not how strong the response is. Sermorelin's job is to fire a GH pulse and then get out of the way so feedback can regulate the next one [3]. The response is measured by IGF-1 at baseline and around 90 days.
How does sermorelin's half-life compare to CJC-1295?
Sermorelin lasts about 11 to 12 minutes; CJC-1295 with its drug-affinity-complex modification lasts about 5.8 to 8.1 days [1][5]. The long half-life allows weekly dosing but replaces the natural pulse with continuous stimulation. Sermorelin's short half-life keeps the pulsatile rhythm intact.
References
- Sermorelin acetate: clinical pharmacology and dosing RxList / FDA-approved Geref prescribing information, 2021. Geref prescribing information. https://www.rxlist.com/sermorelin-acetate-drug.htm
- Incorporation of D-Ala2 in growth hormone-releasing hormone-(1-29)-NH2 increases the half-life and decreases metabolic clearance in normal men Journal of Clinical Endocrinology & Metabolism, 1994. PMID: 7962295. https://pubmed.ncbi.nlm.nih.gov/7962295/
- Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? Clinical Interventions in Aging, 2006. PMID: 18046908. https://pmc.ncbi.nlm.nih.gov/articles/PMC2699646/
- The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes Diabetes Metab Res Rev, 2009. PMC4153414. https://pmc.ncbi.nlm.nih.gov/articles/PMC4153414/
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults Journal of Clinical Endocrinology & Metabolism, 2006. PMID: 16352683. https://pubmed.ncbi.nlm.nih.gov/16352683/
- Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency BioDrugs, 1999. PMID: 18031173. https://pubmed.ncbi.nlm.nih.gov/18031173/
